UF/IFAS scientist secures $3.5M grant to study soil micro-predators
UF researchers has been awarded by the USDA NIFA to study micro-predators and share research findings to promote crop productivity and sustainable soil-health management.
Kriya Highlights Positive Preclinical Data for KRIYA-586, a Gene Therapy Product Candidate for Thyroid Eye Disease (TED), at ESOPRS Annual Meeting
UF Startup Kriya Therapeutics, a biopharmaceutical company developing gene therapies, announced preclinical data from its gene therapy program for thyroid eye disease (TED).
Trilogy Health Services Joins eBrief™ Early Adopter Program
UF Innovate | Accelerate resident client etectRx™ announced an eBrief Early Adopter Program (EAP) partnership with Trilogy Health Services, a senior care communities thought leader and provider.
GatorPitch Brings Fresh University of Florida Startups to Miami
UF Innovate and Mana Tech’s GatorPitch Miami – November 7
Carolyn M. Tucker, Ph.D., receives President’s Lifetime Achievement Award
In recognition of her work to build healthier communities and provide hundreds with power over cancer, Carolyn M. Tucker has received a 2024 President’s Lifetime Achievement Award from the office of U.S. President Joe Biden.
UF Researcher Helping Make Structures Safer After Surfside Disaster
Three years after the Surfside disaster, UF researcher Jennifer Bridge has helped shape new legislation to improve building inspections for condominiums and co-ops in Florida by analyzing inspection reports and creating consistent statewide forms.
Tech Tuesday: Leaders of Woman Entrepreneur Group Support Tech Workers
In this week’s Tech Tuesday, UF Innovate host Bethany Gaffey speaks with the leader of a mentorship group supporting women in tech.
“Cuddle hormone” oxytocin may provide pain relief and help curb harmful opioid use
University of Florida researchers are investigating whether synthetic oxytocin can be used in conjunction with prescription drugs to help curb opioid addictions, especially in susceptible older adults.
Axogen Completes Submission of Biologics License Application to U.S. Food and Drug Administration for Avance Nerve Graft®
UF startup Axogen, Inc., a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, announced that it has completed the rolling submission process for its Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for Avance Nerve Graft®. “I am proud of the significant progress our team has […]
Gene Therapy Restores Vision in First-Ever Trial for Rare, Inherited Blindness
A gene therapy developed by University of Florida scientists, which restored useful vision to most patients with the rare, inherited blindness known as Leber congenital amaurosis type I, or LCA1, in a small trial.